Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 1 results out of 1                                
                                
                                                Data Insights
                                                
                                        Vilamakitug by XBiotech for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
Vilamakitug is under clinical development by XBiotech and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas. According to...